Search results for "REVASCULARIZATION"

showing 10 items of 159 documents

Total Ischemic Event Reduction With Rivaroxaban After Peripheral Arterial Revascularization in the VOYAGER PAD Trial

2021

Patients with peripheral artery disease (PAD) undergoing lower extremity revascularization (LER) are at high risk of major adverse limb and cardiovascular events. The VOYAGER PAD (Efficacy and Safety of Rivaroxaban in Reducing the Risk of Major Thrombotic Vascular Events in Subjects With Symptomatic Peripheral Artery Disease Undergoing Peripheral Revascularization Procedures of the Lower Extremities) trial demonstrated that rivaroxaban 2.5 mg twice daily reduced first events by 15%. The benefit of rivaroxaban on total (first and subsequent) events in this population is unknown.This study sought to evaluate the total burden of vascular events in patients with PAD after LER and the efficacy o…

MaleLower extremity revascularizationmedicine.medical_specialtyArterial diseasemedicine.medical_treatmentGlobal HealthRevascularizationPeripheral Arterial DiseaseRivaroxabanIschemiaInternal medicineHumansMedicineAgedRivaroxabanDose-Response Relationship Drugbusiness.industryIncidencefood and beveragesMiddle AgedPeripheralbody regionsTreatment OutcomeLower ExtremityArterial revascularizationCardiologyDrug Therapy CombinationCardiology and Cardiovascular MedicinebusinessVascular Surgical ProceduresFactor Xa Inhibitorsmedicine.drugJournal of the American College of Cardiology
researchProduct

ST-segment elevation myocardial infarction: Management and association with prognosis during the COVID-19 pandemic in France.

2021

Systems of care have been challenged to control progression of the COVID-19 pandemic. Whether this has been associated with delayed reperfusion and worse outcomes in French patients with ST-segment elevation myocardial infarction (STEMI) is unknown.Aim: To compare the rate of STEMI admissions, treatment delays, and outcomes between the first peak of the COVID-19 pandemic in France and the equivalent period in 2019.Methods: In this nationwide French survey, data from consecutive STEMI patients from 65 centres referred for urgent revascularization between 1 March and 31 May 2020, and between 1 March and 31 May 2019, were analysed. The primary outcome was a composite of in-hospital death or no…

MaleMESH: Hyperlipidemiasmedicine.medical_treatmentMESH: ComorbidityComorbidity030204 cardiovascular system & hematologyMESH: Health Care SurveysMESH: HypertensionMESH: Procedures and Techniques Utilization0302 clinical medicinePatient AdmissionInterquartile rangeMESH: Risk FactorsRisk FactorsST segmentMESH: COVID-19030212 general & internal medicineMyocardial infarctionHospital MortalityMESH: Treatment Outcomeeducation.field_of_studyMESH: Middle AgedCardiogenic shockSmokingMESH: Patient Acceptance of Health CareGeneral MedicineMESH: Heart Rupture Post-InfarctionMiddle AgedPrognosis[SDV.MHEP.CSC] Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemTreatment OutcomeHypertensionCardiologyFemaleStentsFranceCardiology and Cardiovascular MedicineSCA ST+MESH: Percutaneous Coronary Interventionmedicine.medical_specialtyMESH: PandemicsMESH: SmokingMESH: Diabetes MellitusPopulationComplications mécaniquesHyperlipidemiasRevascularizationMESH: PrognosisTime-to-TreatmentSTEMI03 medical and health sciencesPercutaneous Coronary Intervention[SDV.MHEP.CSC]Life Sciences [q-bio]/Human health and pathology/Cardiology and cardiovascular systemInternal medicineLockdownmedicineDiabetes MellitusHumansMESH: SARS-CoV-2MESH: Time-to-TreatmentMESH: Hospital MortalityMESH: ST Elevation Myocardial InfarctioneducationPandemicsHeart Rupture Post-InfarctionMESH: Humansbusiness.industryMESH: Patient AdmissionSARS-CoV-2Percutaneous coronary interventionCOVID-19Patient Acceptance of Health Caremedicine.diseaseComorbidityMESH: MaleMESH: FranceMESH: Stents[SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologieHealth Care SurveysST Elevation Myocardial Infarction[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieMechanical complicationsbusinessMESH: FemaleProcedures and Techniques UtilizationConfinementArchives of cardiovascular diseases
researchProduct

Minimally invasive superficial temporal artery to middle cerebral artery bypass through a minicraniotomy: benefit of three-dimensional virtual realit…

2009

Object The aim of the authors in this study was to introduce a minimally invasive superficial temporal artery to middle cerebral artery (STA-MCA) bypass surgery by the preselection of appropriate donor and recipient branches in a 3D virtual reality setting based on 3-T MR angiography data. Methods An STA-MCA anastomosis was performed in each of 5 patients. Before surgery, 3-T MR imaging was performed with 3D magnetization-prepared rapid acquisition gradient echo sequences, and a high-resolution CT 3D dataset was obtained. Image fusion and the construction of a 3D virtual reality model of each patient were completed. Results In the 3D virtual reality setting, the skin surface, skull surface…

MaleMiddle Cerebral Arterymedicine.medical_specialtyAnastomosisVirtual realityMagnetic resonance angiographyUser-Computer InterfaceImaging Three-DimensionalPredictive Value of Testsmedicine.arteryPreoperative CareSkin surfacemedicineHumansMinimally Invasive Surgical ProceduresAgedCerebral Revascularizationmedicine.diagnostic_testbusiness.industryInfarction Middle Cerebral ArteryIntracranial AneurysmGeneral MedicineMiddle AgedSuperficial temporal arteryTemporal ArteriesDextroscopeBypass surgeryMiddle cerebral arterySurgeryNeurology (clinical)RadiologybusinessCraniotomyMagnetic Resonance AngiographyNeurosurgical Focus
researchProduct

Off-pump versus on-pump myocardial revascularization in patients with ST-segment elevation myocardial infarction: A randomized trial

2009

Objective Conventional cardioplegic arrest coronary artery bypass grafting after ST-segment elevation myocardial infarction is associated with high mortality and morbidity. The benefits of off-pump surgery have been suggested. This study randomly evaluated the impact of the off-pump technique on clinical results. Methods Between February 2002 and October 2007, 128 patients with ST-segment elevation myocardial infarction who underwent myocardial revascularization within 48 hours from the onset of symptoms were randomly assigned to 2 groups: on-pump group (66 patients/51.5%) and off-pump group (63 patients/48.5%). The primary end point was the incidence of in-hospital death and outcomes (low …

MalePulmonary and Respiratory MedicineCardiac function curvemedicine.medical_specialtyTime FactorsOff-pump myocardial revascularization on-pump myocardial revascularization ST-segment elevation myocardial infarctionmedicine.medical_treatmentCoronary Artery Bypass Off-PumpMyocardial Infarctionlaw.inventionlawInternal medicineMyocardial RevascularizationCardiopulmonary bypassHumansMedicineMyocardial infarctionAgedbusiness.industryCardiogenic shockST elevationPercutaneous coronary interventionPerioperativeMiddle Agedmedicine.diseaseIntensive care unitCardiologyFemaleSurgeryCardiology and Cardiovascular MedicinebusinessThe Journal of Thoracic and Cardiovascular Surgery
researchProduct

Procedural, Functional and Prognostic Outcomes Following Recanalization of Coronary Chronic Total Occlusions. Results of the Iberian Registry.

2019

Introduction and objectives: There is current controversy regarding the benefits of percutaneous recanalization (PCI) of chronic total coronary occlusions (CTO). Our aim was to determine acute and follow-up outcomes in our setting. Methods: Two-year prospective registry of consecutive patients undergoing PCI of CTO in 24 centers. Results: A total of 1000 PCIs of CTO were performed in 952 patients. Most were symptomatic (81.5%), with chronic ischemic heart disease (59.2%). Previous recanalization attempts had been made in 15%. The mean SYNTAX score was 19.5 +/- 10.6 and J-score was > 2 in 17.3%. A retrograde procedure was performed in 92 patients (9.2%). The success rate was 74.9% and was hi…

MaleReoperationmedicine.medical_specialtyPercutaneousmedicine.medical_treatmentPerforation (oil well)Myocardial Ischemia030204 cardiovascular system & hematology03 medical and health sciencesPercutaneous Coronary InterventionPostoperative Complications0302 clinical medicineInternal medicineMyocardial RevascularizationmedicineHumansProspective StudiesRegistriesMyocardial infarctionProspective cohort studyUltrasonography InterventionalAgedPortugalbusiness.industryMortality ratePercutaneous coronary interventionGeneral Medicinemedicine.diseaseTreatment OutcomeCoronary OcclusionSurgery Computer-AssistedSpainCoronary occlusionChronic DiseaseConventional PCICardiologyFemaleCTO Cardiopatía isquémica crónica Chronic ischemic cardiomyopathy Chronic total occlusions IVUS OCT Oclusiones crónicasbusiness
researchProduct

Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI…

2001

Summary Background Despite the use of aspirin, there is still a risk of ischaemic events after percutaneous coronary intervention (PCI). We aimed to find out whether, in addition to aspirin, pretreatment with clopidogrel followed by long-term therapy after PCI is superior to a strategy of no pretreatment and short-term therapy for only 4 weeks after PCI. Methods 2658 patients with non-ST-elevation acute coronary syndrome undergoing PCI in the CURE study had been randomly assigned double-blind treatment with clopidogrel (n=1313) or placebo (n=1345). Patients were pretreated with aspirin and study drug for a median of 6 days before PCI during the initial hospital admission, and for a median o…

MaleRiskAcute coronary syndromePrasugrelTiclopidinemedicine.medical_treatmentMyocardial InfarctionCoronary DiseaseDouble-Blind MethodPreoperative CaremedicineMyocardial RevascularizationHumansMyocardial infarctionProspective Studiescardiovascular diseasesAngioplasty Balloon CoronaryAgedProportional Hazards ModelsManagement of acute coronary syndromeAspirinbusiness.industryPercutaneous coronary interventionGeneral MedicineMiddle AgedClopidogrelmedicine.diseaseSurvival AnalysisClopidogrelLogistic ModelsTreatment OutcomeAnesthesiaConventional PCIFemalebusinessElinogrelPlatelet Aggregation Inhibitorsmedicine.drug
researchProduct

A novel approach to define risk of stent thrombosis after percutaneous coronary intervention with drug-eluting stents: the DERIVATION score.

2009

Recent studies of drug-eluting stents (DES) use in routine clinical practice have led to concern regarding their long-term safety and to questions about the adequacy of current antiplatelet therapy guidelines. This study sought to derivate a risk score for predicting stent thrombosis after drug-eluting stenting. The large single center DES Real-world Incremental Value in the erA of percutaneous revascularizaTION (DERIVATION) database, collecting data about 1,377 patients of any age undergoing PCI with DES as treatment for symptomatic coronary artery disease, was use for this purpose. Logistic regression and bootstrap procedure were used to select correlates of stent thrombosis that were sub…

MaleRiskmedicine.medical_specialtyDatabases Factualmedicine.medical_treatmentRevascularizationCoronary AngiographyPredictive scoreCoronary artery diseaseAngioplastyInternal medicineMedicineHumansProspective StudiesAcute Coronary SyndromeAngioplasty Balloon CoronaryAgedFramingham Risk Scorebusiness.industryStent thrombosis.Percutaneous coronary interventionDrug-Eluting StentsThrombosisGeneral MedicineOdds ratioMiddle Agedmedicine.diseasePrognosisThrombosisLogistic ModelsConventional PCIMultivariate AnalysisCardiologyFemaleRadiologyDrug-eluting stentCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation InhibitorsFollow-Up StudiesForecastingClinical research in cardiology : official journal of the German Cardiac Society
researchProduct

Limitations of Clinical History for Evaluation of Patients With Acute Chest Pain, Non-Diagnostic Electrocardiogram, and Normal Troponin

2007

Decision making and risk stratification for patients with acute chest pain, nondiagnostic electrocardiogram results, and normal troponin levels are challenging. The aim of this study was to optimize the clinical history for the evaluation of these patients. A total of 1,011 patients presenting to an emergency department were included. The following data were collected: clinical presentation (pain characteristics and number of pain episodes), coronary risk factors, previous ischemic heart disease, and extracardiac vascular disease (peripheral artery disease, stroke, or creatinine >1.4 mg/dl). Two different predictive models were calculated according to the end points: model 1 for 1-year majo…

MaleThoraxChest Painmedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionMyocardial IschemiaRevascularizationRisk AssessmentElectrocardiographySex FactorsRisk FactorsInternal medicineDiabetes MellitusMyocardial RevascularizationHumansMedicineMyocardial infarctionStrokePeripheral Vascular Diseasesmedicine.diagnostic_testbiologybusiness.industryVascular diseaseTroponin IAge FactorsModels CardiovascularEmergency departmentMiddle Agedmedicine.diseaseTroponinHospitalizationStrokeCreatinineAcute DiseaseExercise Testbiology.proteinCardiologyRegression AnalysisFemaleEmergency Service HospitalCardiology and Cardiovascular MedicinebusinessElectrocardiographyThe American Journal of Cardiology
researchProduct

A multicenter 12-month experience with a new iliac side-branched device for revascularization of hypogastric arteries.

2016

Abstract Objective The aim of this study was to investigate the 1-year safety and efficacy of a new iliac side-branched device (IBD) for revascularization of the hypogastric arteries. Methods Patients receiving the E-liac (Jotec GmbH, Hechingen, Germany) side-branched device at six German vascular centers either as a stand-alone procedure or in combination with abdominal aortic aneurysm exclusion were included in a prospectively created data bank. Collected data were analyzed for baseline characteristics, procedural events, and clinical follow-up; variables included endoleaks, reinterventions, and internal iliac artery (IIA) patency. Results Between January 2012 and January 2015, a total of…

MaleTime FactorsDatabases FactualEndoleakComputed Tomography Angiographymedicine.medical_treatmentBlood Loss Surgical030204 cardiovascular system & hematologyEndovascular aneurysm repair030218 nuclear medicine & medical imaging0302 clinical medicineRisk FactorsGermanyMedicineHospital MortalityAged 80 and overEndovascular ProceduresGraft Occlusion VascularArteriesMiddle AgedCommon iliac arteryInternal iliac arteryAbdominal aortic aneurysmTreatment OutcomeIliac AneurysmFemaleStentsRadiologyCardiology and Cardiovascular Medicinemedicine.medical_specialtyRevascularizationProsthesis DesignPelvis03 medical and health sciencesBlood Vessel Prosthesis ImplantationAneurysmBlood vessel prosthesismedicine.arteryHumansVascular PatencyAgedRetrospective Studiesbusiness.industryExternal iliac arteryAngiography Digital Subtractionmedicine.diseaseSurgeryBlood Vessel ProsthesisFeasibility StudiesSurgerybusinessJournal of vascular surgery
researchProduct

Retrograde Recanalization of Chronic Total Occlusions in Europe: Procedural, In-Hospital, and Long-Term Outcomes From the Multicenter ERCTO Registry.

2015

BACKGROUND A retrograde approach improves the success rate of percutaneous coronary interventions (PCIs) for chronic total occlusions (CTOs). OBJECTIVES The authors describe the European experience with and outcomes of retrograde PCI revascularization for coronary CTOs. METHODS Follow-up data were collected from 1,395 patients with 1,582 CTO lesions enrolled between January 2008 and December 2012 for retrograde CTO PCI at 44 European centers. Major adverse cardiac and cerebrovascular events were defined as the composite of cardiac death, myocardial infarction, stroke, and further revascularization. RESULTS The mean patient age was 62.0 +/- 10.4 years; 88.5% were men. Procedural and clinical…

MaleTime FactorsIncidenceMiddle AgedCoronary AngiographySettore MED/11 - Malattie Dell'Apparato CardiovascolareHospitalsEuropeElectrocardiographyPercutaneous Coronary InterventionPostoperative ComplicationsTreatment OutcomeCoronary Occlusionchronic total occlusionsJ-CTO scoreChronic DiseaseHumansretrograde PCI revascularizationFemaleHospital MortalityProspective StudiesRegistrieschronic total occlusionFollow-Up StudiesJournal of the American College of Cardiology
researchProduct